Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

凯络 - NMPA Drug Approval Details

Approvals/NMPA/Carvedilol Capsules

Approved

化学药品

Carvedilol Capsules

北大医药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 30, 2020
Approval ID: 7Leafm01seA
Company: 北大医药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7Leafm01seA
Approval Number: 国药准字H20000568
Generic Name: 卡维地洛胶囊
Generic Name En: Carvedilol Capsules
Trade Name: 凯络
Brand Name: 凯络
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 10mg
Reg Date: 2020-09-30
Company Name: 北大医药股份有限公司
Production Company Name: 北大医药股份有限公司
Production Company Address: 重庆市北碚区水土镇方正大道21号附1号
Company Detail Path: /organization/pku-healthcare-corp-ltd
Production Company Detail Path: /organization/pku-healthcare-corp-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 30, 2020

Approval ID

7Leafm01seA

Type

化学药品

Back to NMPA Approvals